Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR002345)
Article History
Received: 4 April 2023
Revised: 5 July 2023
Accepted: 10 July 2023
First Online: 7 August 2023
Change Date: 2 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41386-023-01746-6
Competing interests
: EL: Consultant for Prodeo, Pritikin ICR, IngenioRx, Boehringer-Ingelheim, and Merck. Research funding from Janssen. Patent application pending for sigma-1 receptor agonists for COVID-19. JT: scientific advisory board of Precision Mental Wellness. PA: scientific advisory board of Headspace Health, Koa Health, and Chorus Sleep.